1AI 0.00% 0.7¢ algorae pharmaceuticals limited

research v. Phase II exam, page-13

  1. 2,983 Posts.
    lightbulb Created with Sketch. 69
    +1

    with emphasis,

    @whytee has nailed a strong summary and reason followers of the science:

    "Right now though the market knows plans for commercialisation have been shelved and possibly concluded that NTcell "doesn't work." I think the second part is premature, since 3 of the first 4 patients do seem to have had a sustained durable response now over several years.

    "I [too] belong to the group that believes [1] that embryological dopaminergic implants have been shown to work provided that the treatment is given before global damage is too severe, and [2] that side effects can be limited by not implanting an excessive number of dopaminergic cells and [3] the cells are implanted by distributing them uniformly along the length of the putamen."

    I suspect the intention of going to market has not been shelved, just yet, even tho the application has had to be put on hold

    I think we bang the "time" drum for as long as it takes as time seems to be the crucial fulcrum nearly everywhere i look including ncbi studies, the door remains widely open
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.000(0.00%)
Mkt cap ! $11.81M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $23.34K 3.334M

Buyers (Bids)

No. Vol. Price($)
15 3931572 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 4990 1
View Market Depth
Last trade - 10.59am 11/11/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.